Search Results - "Ong, Eugenia Z"

Refine Results
  1. 1
  2. 2
  3. 3

    Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion by Ong, Eugenia Z, Chan, Kuan Rong, Ooi, Eng Eong

    Published in PLoS pathogens (01-09-2016)
    “…Eugenia Z. Ong Affiliation: Experimental Therapeutics Centre, Agency for Science, Technology, and Research, Singapore Kuan Rong Chan Affiliation: Programme in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial by Kalimuddin, Shirin, Chan, Yvonne F Z, Sessions, October M, Chan, Kuan Rong, Ong, Eugenia Z, Low, Jenny G, Bertoletti, Antonio, Ooi, Eng Eong

    Published in Frontiers in immunology (10-03-2023)
    “…Vaccination induces an adaptive immune response that protects against infectious diseases. A defined magnitude of adaptive immune response that correlates with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A fast-growing dengue virus mutant reveals a dual role of STING in response to infection by Ng, Wy Ching, Kwek, Swee Sen, Sun, Bo, Yousefi, Meisam, Ong, Eugenia Z, Tan, Hwee Cheng, Puschnik, Andreas S, Chan, Kuan Rong, Ooi, Yaw Shin, Ooi, Eng Eong

    Published in Open biology (01-12-2022)
    “…The four dengue viruses (DENVs) have evolved multiple mechanisms to ensure its survival. Among these mechanisms is the ability to regulate its replication…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution by Ong, Eugenia Z, Kalimuddin, Shirin, Chia, Wen Chong, Ooi, Sarah H, Koh, Clara WT, Tan, Hwee Cheng, Zhang, Summer L, Low, Jenny G, Ooi, Eng Eong, Chan, Kuan Rong

    Published in EBioMedicine (01-03-2021)
    “…The coronavirus disease-19 (COVID-19) pandemic has cost lives and economic hardships globally. Various studies have found a number of different factors, such…”
    Get full text
    Journal Article
  12. 12

    Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection by Yau, Clement, Gan, Esther Shuyi, Kwek, Swee Sen, Tan, Hwee Cheng, Ong, Eugenia Z., Hamis, Noor Zayanah, Rivino, Laura, Chan, Kuan Rong, Watanabe, Satoru, Vasudevan, Subhash G., Ooi, Eng Eong

    Published in EBioMedicine (01-11-2020)
    “…The emergence of Zika virus (ZIKV) as an important cause of congenital and childhood developmental disorders presents another challenge to global health…”
    Get full text
    Journal Article
  13. 13

    Therapeutic antibodies as a treatment option for dengue fever by Chan, Kuan Rong, Ong, Eugenia Z, Ooi, Eng Eong

    Published in Expert review of anti-infective therapy (01-11-2013)
    “…Dengue fever is the most prevalent mosquito-borne viral disease globally with about 100 million cases of acute dengue annually. Severe dengue infection can…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children by Zhong, Youjia, Kang, Alicia Y. H., Tay, Carina J. X., Li, Hui’ En, Elyana, Nurul, Tan, Chee Wah, Yap, Wee Chee, Lim, Joey M. E., Le Bert, Nina, Chan, Kuan Rong, Ong, Eugenia Z., Low, Jenny G., Shek, Lynette P., Tham, Elizabeth Huiwen, Ooi, Eng Eong

    Published in Nature medicine (01-05-2024)
    “…The paucity of information on longevity of vaccine-induced immune responses and uncertainty of the correlates of protection hinder the development of…”
    Get full text
    Journal Article
  18. 18

    Dengue virus compartmentalization during antibody-enhanced infection by Ong, Eugenia Z., Zhang, Summer L., Tan, Hwee Cheng, Gan, Esther S., Chan, Kuan Rong, Ooi, Eng Eong

    Published in Scientific reports (13-01-2017)
    “…Secondary infection with a heterologous dengue virus (DENV) serotype increases the risk of severe dengue, through a process termed antibody-dependent…”
    Get full text
    Journal Article
  19. 19

    Phase 1 Trial of a Therapeutic Anti–Yellow Fever Virus Human Antibody by Low, Jenny G, Ng, Justin H.J, Ong, Eugenia Z, Kalimuddin, Shirin, Wijaya, Limin, Chan, Yvonne F.Z, Ng, Dorothy H.L, Tan, Hwee-Cheng, Baglody, Anjali, Chionh, Yok-Hian, Lee, Debbie C.P, Budigi, Yadunanda, Sasisekharan, Ram, Ooi, Eng-Eong

    Published in The New England journal of medicine (30-07-2020)
    “…A phase 1a–1b trial of TY014, an IgG1 anti–yellow fever virus monoclonal antibody, did not identify worrisome safety signals. Ten participants were randomly…”
    Get full text
    Journal Article
  20. 20